Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immuno-deficiency Virus (HIV) Disease”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Not applicableStudy completedNCT01541085
What this trial is testing

An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART

Who this might be right for
Human Immunodeficiency Virus; HIV
Janssen-Cilag S.p.A. 33
Testing effectiveness (Phase 2)Temporarily pausedNCT03312244
What this trial is testing

Pyridostigmine as Immunomodulator in People Living With HIV

Who this might be right for
HIV-1-infectionCD4+ T LymphocytopeniaImmune Deficiency+1 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 60
Testing effectiveness (Phase 2)Ended earlyNCT06032546
What this trial is testing

Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382

Who this might be right for
Human Immuno-deficiency Virus (HIV) Disease
AbbVie 163
Early research (Phase 1)UnknownNCT00858923
What this trial is testing

Safety Study of the HemoModulator System for the Treatment of Patients With Human Immunodeficiency Virus (HIV)

Who this might be right for
HIVHIV Infections
Energex Systems, Inc. 10
Early research (Phase 1)Study completedNCT04554966
What this trial is testing

Study to Assess Adverse Events and How Intravenous (IV) or Subcutaneous (SC) ABBV-382 Moves Through the Body of Adult Participants With Human Immuno-Deficiency Virus (HIV-1)

Who this might be right for
Human Immunodeficiency Virus (HIV)
AbbVie 54
Early research (Phase 1)Study completedNCT02304185
What this trial is testing

Safety, Tolerability and Immunogenicity Study of 2 Dose Levels of Trimeric Glycoprotein140 (gp140) in Healthy Adult Volunteers

Who this might be right for
Healthy
Crucell Holland BV 50
Testing effectiveness (Phase 2)Study completedNCT02315703
What this trial is testing

Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 393
Large-scale testing (Phase 3)Study completedNCT02075593
What this trial is testing

ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection

Who this might be right for
Infection, Human Immunodeficiency VirusHIV InfectionsArthralgia
ViiV Healthcare 4